Hims & Hers Stock Soars on New Menopause Care Expansion – What Comes Next?
Hims & Hers’ women’s health platform (Hers) now offers specialized menopause and perimenopause care investors.hims.com. The new service is aimed at improving access to hormone therapies (estradiol, progesterone, etc.) for symptoms like hot flashes and sleep issues, expanding a platform that already serves over 500,000 women. The October 15 jump in HIMS stock was driven by the menopause announcement. Investors saw the new specialty as a major driver of future growth, helping Hims & Hers address a long-ignored need in women’s health. As Benzinga reported, the stock closed the day up about 10–13% (trading near $60) after the news benzinga.com.